BioSig shareholders approve share increase, incentive plan expansion, and Yorkville financing; Streamex vote adjourned

Streamex Corp.

Shareholders approved increasing authorized common shares from 200M to 500M (Ninth Certificate of Amendment filed).
Approved amendment to 2023 Long-Term Incentive Plan, increasing share reserve by 10,359,211 to 14,735,806 shares.
Approved convertible debenture share issuance to Yorkville (YA II PN, Ltd.) for potential future financing.
Approved SEPA (Standby Equity Purchase Agreement) with Yorkville allowing issuance of up to 19.99% of outstanding shares.
Special meeting adjourned on Proposal 1 (issuance of ~109M shares for Streamex acquisition) pending Nasdaq approval; reconvened Sept 26, 2025.

item 5.02item 5.07item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.